|
⚲
|
| Keyboard |
| Bertolini Robert J
✚
|
|
|---|---|
| CIK # | 0001270263 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001270263] | |
| 4 | [0001270263] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Charles River Laboratories International Inc | |
| Bertolini Robert J | |
| Bristol Myers Squibb Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2024-05-13 | Grant | 1,311 | $228.41 | 299,446 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2024-05-13 | Grant | 394 | $228.41 | 89,994 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2024-05-13 | Grant | 559 | $228.41 | 127,681 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2023-05-15 | Grant | 468 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2023-05-15 | Grant | 1,669 | $192.36 | 321,049 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2023-05-15 | Grant | 664 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2022-05-11 | Grant | 405 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2022-05-11 | Grant | 575 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2022-05-11 | Grant | 1,582 | $222.31 | 351,694 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2021-05-07 | Grant | 355 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2021-05-07 | Grant | 248 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2021-05-07 | Grant | 1,151 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2021-03-31 | Grant | 554.41 | $63.13 | 35,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2021-02-01 | Grant | 3,054.17 | $62.21 | 190,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-12-31 | Grant | 564.24 | $62.03 | 35,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-09-30 | Grant | 580.53 | $60.29 | 35,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2020-06-30 | Grant | 595.24 | $58.80 | 35,000 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2020-05-20 | Option exercise | 3,530 | $52.29 | 184,584 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2020-05-20 | Sell | 3,530 | $174.58 | 616,267 |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2020-05-20 | Option exercise | 3,530 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||